Updated COVID-19 Healthcare Professional Letter

May 11, 2020

Dear Health Care Professional,

As the COVID-19 situation continues to unfold, there is no doubt you and your patients have been impacted. On behalf of everyone at Takeda, I would like to extend my sincere gratitude for everything you, and all front-line workers, have done to provide care to those that need it most during these unprecedented times. 

As we continue to plan for Canada’s return to more regular activity, I want to take this opportunity to follow up on our prior communication from March 2020 and ensure you have the information you need about Takeda’s plans to resume day-to-day activities in the coming months.

First and foremost, we will continue to respect both the guidance of public health authorities and your own preferences for working together during this time. For the foreseeable future, our employees will continue working remotely using digital engagement, rather than making in-person visits.  We are here to support you. If your current circumstances mean you prefer not to connect with your Takeda representative at this time, that decision will be respected until you indicate otherwise.

While how we connect will be different, our focus continues to be on effectively supporting both you and your patients. We will concentrate efforts on medical education, sample support and product continuity. We are also working to enhance virtual patient support across our therapeutic areas, including enhanced patient support program coordination.

Finally, we will strive to ensure you have the educational tools and guidance you need to manage your patients who rely on Takeda therapies throughout the COVID-19 situation and beyond. I am proud of the support we have been able to offer patients, health care professionals like you, and the community at large – including financial support to our communities through grants and donations, nursing and product logistics support through our Patient Support Services program, expanded access to knowledge-sharing platforms, and virtual training solutions.

While COVID-19 is currently defining how we work, it cannot define why we work – and our values will continue to drive our commitment to you, your patients, and the broader health care community.

As we work through this together, I want to thank you for your understanding and continued support. Should you have any questions or wish to discuss how better we can support you, please do not hesitate to reach out to your Takeda representative.

Sincerely,

Gamze Yüceland
General Manager